DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Financings

DiaMedica Therapeutics Inc.

Financings

RaiseDate
Private placement of common shares
Closed: US$30.1M raised · US$3.5 a share
Buyers: Thomas von Koch (2,857,142 common shares through TomEnterprise Private AB for US$10,000,000; approximately 16.2% after closing); Trill AB (1,542,857 common shares for US$5,000,000; approximately 13.1% after closing); NFS/FMTC Roth IRA FBO Richard Jacinto II (400,000 common shares for US$1,400,000; approximately 9.6% after closing)
Insiders: Certain non-management related parties acquired an aggregate of $16.8 million or 4,799,999 common shares
Use of proceeds: To advance ongoing research and development activities
Jul 23, 2025

Read by 6ix AI from the company's releases